Trial Profile
Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Novartis; Novartis Pharmaceuticals
- 12 May 2012 NCT reports actual patient number is 254.
- 12 May 2012 NCT reports actual patient number is 254.
- 04 May 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00099931).